Trials / Sponsors / Attaya Suvannasankha
Attaya Suvannasankha
Academic / Other · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy Multiple Myeloma | Phase 2 | 2021-12-06 |
| Completed | Role of Osteocytes in Myeloma Bone Disease Multiple Myeloma | — | 2014-10-07 |
| Terminated | Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy Refractory Multiple Myeloma | Phase 2 | 2013-09-01 |
| Completed | Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2010-08-27 |
| Completed | Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple M Multiple Myeloma | Phase 2 | 2007-10-01 |